Trump’s White House Pharmacy Had a Bit of a Pill Problem

January 26, 2024 · High Times

A lengthy new report from the Department of Defense found that during Trump’s administration, the White House Medical Unit was mishandling dangerous prescription drugs.

The 80-page document released on January 8 detailed inappropriate mishandling of pharmaceuticals and their respective prescribing practices. The investigation into this matter began in 2018 after the Inspector General of the Department of Defense received complaints which included shoddy record keeping, overuse of brand name medications instead of cheaper generic alternatives, mishandling of medications such as one person picking up a prescription for another and so on. 

“Without oversight from qualified pharmacy staff, the White House Medical Unit’s pharmaceutical management practices may have been subject to prescribing errors and inadequate medication management, increasing the risk to the health and safety of patients treated within the unit. Additionally, the White House Medical Unit’s pharmaceutical management practices ineffectively used DoD funds by obtaining brand‑name medications instead of generic equivalents and increased the risk for the diversion of controlled substances,” the report said.

Over 120 officials were interviewed during the course of the investigation. Several witnesses gave testimony to the Department of Defense in the course of this investigation, almost all of whom described a very laissez faire environment compared to most pharmacies, or most fast food restaurants for that matter, which have all been under immense pressure from the DEA to crack down on mishandling of controlled substance. Most anyone who has tried to fill a prescription for opioid painkillers or stimulants like Adderall in the last five years can attest to this. 

“Anything that took place at the White House Clinic was never written down, never recorded. [However,] the only record that you ever had that a patient came in and got any sort of medication would have been if it was a controlled substance that we were required to document for the pharmacy. But if you came in and got any other prescription medication that wasn’t classified as a controlled substance there would be no record that you came in and did anything,” one witness told the Department of Defense, while another said that it was common practice to make “go-bags” of drugs like Ambien and Provigil for White House staffers before overseas trips.

In addition to mishandling of medications, the investigation found that taxpayers have been footing the bill for egregious overuse of brand name medications in lieu of their generic alternatives. Between 2017 and 2019, for instance, the White House spent $46,500 for Ambien and $98,000 for Provigil, which are 174 and 55 times more expensive, respectively, than their generic alternatives. Medical services including prescribing of controlled substances were also found to have been administered to ineligible White House staffers, on an average of six to 20 times a week according to the report. 

“We found that the White House Medical Unit provided a wide range of health care and pharmaceutical services to ineligible White House staff in violation of Federal law and regulation and DoD policy. Additionally, the White House Medical Unit dispensed prescription medications, including controlled substances, to ineligible White House staff,” the report said. “We concluded that all phases of the White House Medical Unit’s pharmacy operations had severe and systemic problems due to the unit’s reliance on ineffective internal controls to ensure compliance with pharmacy safety standards,” the report said.

The Department of Defense report concluded that more stringent and robust policies to prevent such issues in the future, which included establishing stricter controls for how controlled substances are prescribed and distributed as well as establishing stricter controls for who is eligible for White House medical care and who is not.

“We recommend that the Director of the Defense Health Agency, in coordination with the White House Medical Unit Director, develop policy and procedures to manage controlled and non‑controlled medications, including, at a minimum, procurement, storage and inventory, prescribing and dispensing, and disposal,” the report said. “We recommend that the Director of the Defense Health Agency, in coordination with the White House Medical Unit Director, establish controls for White House patient eligibility within the Military Health System.” (Full Story)

In category:Politics
Next Post

Fetterman Opposes Schumer’s Zyn Nicotine Pouch Crackdown For Same ‘Freedom’ Reasons He Backs Marijuana Legalization

Sen. John Fetterman (D-PA) says he doesn’t support Senate Majority Leader Chuck Schumer’s (D-NY) call for a crackdown on the nicotine product Zyn because it’s a matter of “freedom and personal choices,” drawing parallels to his reasons for supporting marijuana…
Previous Post

New York’s Sudden Cancellation Of Marijuana Board Meeting Came At Governor’s Request, Email Suggests

The sudden cancellation of a state cannabis licensing board meeting scheduled for Wednesday left applicants hoping to run weed businesses fuming. After learning of the cancellation Tuesday evening, LakeHouse Cannabis CEO Paul Suits Jr. sent a two page document outlining…
Random Post

Members Of New Hampshire Marijuana Legalization Commission Spar On Details Ahead Of Looming Bill Deadline

With less than a month left before a New Hampshire commission is due to put forward a plan for how to legalize adult-use marijuana sales through a system of state-controlled stores, members were visibly frustrated at a Thursday meeting with…
Random Post

Ukrainian Medical Marijuana Bill That Was Set For Final Vote Is ‘Blocked’ By Hundreds Of ‘Spam’ Amendments, Lawmaker Says

A bill to legalize medical marijuana in Ukraine that was supposed to be taken up for a final vote this week is being effectively blocked, with members of one party filing hundreds of so-called “spam” amendments to procedurally delay passage. Ukraine’s unicameral…
Random Post

EPM301- An Acid in Cannabis That Is Much More Potent Than Cannabinoids Says Dr. Raphael Mechoulam

The prominence of medicinal cannabis and its acceptance in recent times has been majorly built on the effects of cannabinoids. Along with terpenes and other phytochemical molecules, they give rise to a wide range of medicinal effects and recreational effects.…
Random Post

Maine authorities charge 5 in illicit marijuana grow crackdowns

Maine is cracking down on unlicensed marijuana operators, charging five individuals in two separate investigations in the past week. In the most recent instance, Maine State Police on Tuesday responded to a community complaint about two homes in Belgrade, according to the…